BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8371155)

  • 1. Coronary vascular injury following transient coronary artery occlusion: prevention by pretreatment with deferoxamine, dimethylthiourea and N-2-mercaptoproprionyl glycine.
    Patterson E
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1528-35. PubMed ID: 8371155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vascular injury after transient coronary artery occlusion.
    Patterson E; Burow RD; Hung CY; Scherlag BJ
    Lab Invest; 1993 Oct; 69(4):471-82. PubMed ID: 8231114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine pretreatment reduces canine infarct size and oxidative injury.
    Lesnefsky EJ; Repine JE; Horwitz LD
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1103-9. PubMed ID: 2359019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of oxygen-derived free radicals in canine reperfusion arrhythmias.
    Euler DE
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H295-300. PubMed ID: 7840275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals.
    Mitsos SE; Askew TE; Fantone JC; Kunkel SL; Abrams GD; Schork A; Lucchesi BR
    Circulation; 1986 May; 73(5):1077-86. PubMed ID: 3698230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcardiac alteration of neutrophil function relates to myocardial ischaemia/reperfusion injury.
    Hoshida S; Kuzuya T; Fuji H; Oe H; Hori M; Kamada T; Tada M
    Cardiovasc Res; 1993 Mar; 27(3):377-83. PubMed ID: 8490937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury.
    Reddy BR; Kloner RA; Przyklenk K
    Free Radic Biol Med; 1989; 7(1):45-52. PubMed ID: 2753395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury.
    Bolli R; Jeroudi MO; Patel BS; Aruoma OI; Halliwell B; Lai EK; McCay PB
    Circ Res; 1989 Sep; 65(3):607-22. PubMed ID: 2548761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial protection in the occlusion/reperfusion dog model: the role of ischemic necrosis vs reperfusion injury.
    Chagas AC; Pileggi F; Lopes EA; Da-Luz PL
    Braz J Med Biol Res; 1995 Sep; 28(9):951-9. PubMed ID: 8580882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonizing the hydroxyl ion free radical (HO.) does not abolish reperfusion ventricular fibrillation in anesthetized dogs.
    da-Luz PL; Chagas AC; Laurindo FR; Pileggi F
    Braz J Med Biol Res; 1993 May; 26(5):477-89. PubMed ID: 8257937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-2-mercaptopropionylglycine, a scavanger of reactive oxygen species, does not modify the early antiarrhythmic effect of ischaemic preconditioning in anaesthetised dogs.
    Agnes H; Nagy L; Parratt JR; Papp J; VĂ©gh A
    Cardiovasc Drugs Ther; 2004 Nov; 18(6):449-59. PubMed ID: 15770432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of dysfunction in the postischemic 'stunned' myocardium by dimethylthiourea.
    Bolli R; Zhu WX; Hartley CJ; Michael LH; Repine JE; Hess ML; Kukreja RC; Roberts R
    Circulation; 1987 Aug; 76(2):458-68. PubMed ID: 3111744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyl radical production during myocardial ischemia and reperfusion in cats.
    O'Neill CA; Fu LW; Halliwell B; Longhurst JC
    Am J Physiol; 1996 Aug; 271(2 Pt 2):H660-7. PubMed ID: 8770109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of dimethylthiourea to limit tissue necrosis during acute myocardial infarction in rabbits.
    Kingma JG; Yellon DM
    Free Radic Biol Med; 1992; 12(4):263-70. PubMed ID: 1577329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine myocardial reperfusion injury: protection by a free radical scavenger, N-2-mercaptopropionyl glycine.
    Mitsos SE; Fantone JC; Gallagher KP; Walden KM; Simpson PJ; Abrams GD; Schork MA; Lucchesi BR
    J Cardiovasc Pharmacol; 1986; 8(5):978-88. PubMed ID: 2429100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed coronary endothelial protection 24 hours after preconditioning: role of free radicals.
    Kaeffer N; Richard V; Thuillez C
    Circulation; 1997 Oct; 96(7):2311-6. PubMed ID: 9337205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraction band necrosis: its modification by the free radical scavenger N-2-mercaptopropionyl glycine.
    Widman SC; Liang CS; Schenk EA; Hood WB
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):694-701. PubMed ID: 7532745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of normobaric pulmonary oxygen toxicity by hydroxyl radical inhibition.
    Boyce NW; Campbell D; Holdsworth SR
    Clin Invest Med; 1987 Jul; 10(4):316-20. PubMed ID: 2820642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lung tissue oxidation during ischemia/reperfusion by 2-mercaptopropionylglycine.
    Ayene IS; al-Mehdi AB; Fisher AB
    Arch Biochem Biophys; 1993 Jun; 303(2):307-12. PubMed ID: 8512317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart.
    Farber NE; Vercellotti GM; Jacob HS; Pieper GM; Gross GJ
    Circ Res; 1988 Aug; 63(2):351-60. PubMed ID: 3396156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.